Noroclav Injection has a notably broad spectrum of bactericidal activity against the bacteria commonly found in cattle and dogs.
(a)In vitro Noroclav Injection is active against a wide range of clinically important bacteria including:
Gram-positive: Staphylococci (including beta-lactamase producing strains), Streptococci, Corynebacteria, Clostridia, Bacillus anthracis, Actinomyces bovis.
Gram-negative: Escherichia coli (including beta-lactamase producing strains), Salmonella spp, (including beta-lactamase producing strains), Campylobacter spp, Klebsiella spp, Proteus spp, Pasteurellae spp, Fusobacterium necrophorum, Bacteroides spp (including beta-lactamase producing strains), Haemophilus spp, Moraxella spp and Actinobacillus lignieresi.
(b)Noroclav Injection is effective against bacteria which cause a wide range of diseases:
In cattle these include:
Soft tissue infections (e.g. joint/navel ill, abscesses etc.)
In dogs these include:
Respiratory tract infections
Urinary tract infections
Skin and soft tissue infections (e.g. abscesses, pyoderma, anal sacculitis and gingivitis)